Target intelligence / Profile preview

CDKN2A interacting protein N-terminal like pseudogene 1 (CDKN2AIPNLP1)

Target
CDKN2AIPNLP1
Molecular classification
Other (Pseudogene)
01

Overview

CDKN2A interacting protein N-terminal like pseudogene 1 (CDKN2AIPNLP1) is a pseudogene in the human genome. Pseudogenes are genomic sequences similar to normal genes but are non-functional; they do not encode functional proteins and are not considered typical biological drug or therapeutic targets. There is no evidence in the current literature or genetic databases for a direct role or function of CDKN2AIPNLP1 in biological pathways, disease mechanisms, or as a therapeutic target. Unlike some well-studied pseudogenes with regulatory "decoy" functions (such as PTENP1 regulating PTEN), there is no direct evidence or published data indicating such a regulatory role for CDKN2AIPNLP1. The gene is primarily catalogued as a non-functional DNA sequence and lacks known aliases, functional properties, or clinical relevance. The abbreviation and name both refer to a pseudogene, which by definition is not a conventional molecular target (receptor, enzyme, etc.), lacks protein product, and is generally not considered "druggable." Selection of this entry as a drug target is likely incorrect, as there is no evidence supporting its status as a target for therapy, nor association with drug mechanisms, biomarkers, or safety concerns. If you are seeking information about CDKN2AIP or the canonical CDKN2AIP gene (not the "like pseudogene 1" variant), that is a functional gene and should be queried separately.

02

Mechanism of action

None known

03

Biological functions

None established; general pseudogene function may include regulation of gene expression through RNA-mediated effects, but no direct function established for this entity
04

Disease associations

None established for this specific pseudogene; pseudogenes may sometimes have regulatory relevance in cancer or other conditions, but not established for CDKN2AIPNLP1

Beyond the preview

Go deeper on CDKN2A interacting protein N-terminal like pseudogene 1 (CDKN2AIPNLP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CDKN2A interacting protein N-terminal like pseudogene 1 (CDKN2AIPNLP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call